Problems in the implementation of Rational Use of Medicine
description
Transcript of Problems in the implementation of Rational Use of Medicine
Rianto SetiabudyDept. of Pharmacology FKUI
The Launching of IONI
Jakarta, 26 October 2009
Background Irrational use of medicines is a global
problem The examples of this problem:
o Polypharmacyo The use of medicines that are not related to the
diagnosiso Unnecessary use of expensive medicineso Inappropriate use of antibiotics
• The purpose of this discussion is to recognize factors which may hamper the implementation of RUM and to set up strategy to apply it
Outlines
Factors influencing the use of medicine How to critically appraise new drugs? Steps toward the rational
pharmacotherapy
Factors influencing the use of medicine (1)Intrinsic factors:
Do we provide adequate training for the medical students in the Rational Use of Medicine (RUM)?
Drug information:The main source of drug information for the practicing
doctorsWhat do we need? Drug information which is
objective, informative, systematic, and comprehensible (preferably not in local language)
Factors influencing the use of medicine (2)The working group:
Cooperation with industry → “local policy”Conflict of interests
The working environment:The “negative and positive goalkeeper”Overburdened health workers: information for
patients?Poorly maintained equipments
Factors influencing the use of medicine (3)The demand of patients:
Request for injectionReject generic drugsRequest for “patent” or expensive drugsRefill of prescriptionRequest for antibiotics, vitamins, “brain energizers”
The attractiveness of new drugs
Why are doctors inclined to prescribe new drugs?
Introduction of new features The launching of new drugs large
scientific events Image as up-to-date doctors The presence of cases who failed to
respond to the existing treatments Rewards Curiosity
The selling points of new drugs
Better efficacy Better tolerability More simple dosing regimen Shorter treatment period Others:
Less complications Less likely occurrence of resistance Better QOL Better laboratory results
How to critically appraise claim of new drugs?
1. The availability of clinical data: Sample size is adequate? Derived from peer-reviewed journals? Is data from meta-analysis available? Position is clear ? (As adjuvant? For
new cases? Mono therapy? For complicated cases?)
How to critically appraise new drugs?
2. Serious side effects The rarely occurring SAEs are usually not
detectable in the pre-marketing clinical trials
They are usually detected in the post-marketing surveillance
Anasarca and new oral antidiabetic
How to critically appraise new drugs?
3. New drugs appear to have less side effects: This may not be true simply because the
drug is still new In contrast, old drugs with a long list of
side effects may not be necessarily dangerous in reality
E.g.: aspirin, paracetamol, amoxicillin
How to critically appraise new drugs?
4. Long-term side effects are still unknown: The safety and efficacy data of new
drugs are derived from the relatively short clinical trials
Drugs for long-term use require special precaution, e.g. anti-glaucoma, antihypertensive agents, anti arrhytmics, oral hypoglycemic agents, NSAIDS, etc.
QT interval prolongation
How to critically appraise new drugs?
6. Understanding the dramatic reduction of complications associated with a new drug:A new drug is often claimed capable of a
dramatically reduce the complication as compared to that of the conventional treatment. This should be critically assessed.
For example: A study shows that using the conventional drug, the incidence of stroke is 2% per year.
Using the new drug, the incidence of stroke is only 1% per year.
This a 50% reduction (looks very impressive!)
How to critically appraise new drugs? The Relative Risk Reduction (RRR)= 50%But:
The Absolute Risk Reduction (ARR) is 1% (!)More interestingly:
NNT = 1 : ARR = 1 : 1% = 100 means that we have to treat 99 patients to protect only 1 patient from being hit by stroke. The 99 patients take the drug for nothing.
How to critically appraise new drugs?
7. The new drug still works in cases which already failed to respond to other agents: If this occurs, it does not necessarily
mean that this new drug is more effective than the conventional agents because the contrary is also true.
Example: antihypertensive agents
How to critically appraise new drugs? (2)
8. Real clinical benefit felt by the patient: claims of superiority of new drugs should
be sensible by the patient, e.g. reduction of case fatality rate, sequelae, length of hospitalization, risk of amputation, walking distance, etc.
Improvement of various markers is only clinically meaningful if they correlate well with the clinical improvement , e.g. HbA1c, LDL cholesterol, sputum conversion, etc.
How to consistently maintain RUM with regards to the introduction of new drugs? (1)
1. Do not prescribe a drug because of it is new, but because of it is safe, effective, suitable, and affordable
2. Appraise critically the claim of efficacy and safety of new drugs
3. Use EBM as the foundation to prescribe new drugs
4. Assess whether the price of a new drug is worth its superiority
How to consistently maintain RUM with regards to the introduction of new drugs? (1)
5. Find out whether the new drug is a “me-too drug”
6. In general, it is usually wise to wait for a while before one start prescribing new drugs
7. In contrast: do not hesitate to abandon poor old drugs, when the better new ones are available
Steps towards the rational pharmacotherapy (1)
The PROSPECT approachProblem identificationObjective of treatmentSuitable choice of treatmentPrescribing of the drug(s)Education and informationCheck, termination or modification of
treatment
Steps towards the rational pharmacotherapy (2)
Problem identification:One problem may be caused by different etiologies which
require different approaches. E.g., cough could be due to:o Excessive smokingo Chronic obstructive pulmonary disease (COPD)o Asthma o Heart failureo Tuberculosiso Captopril o Malignancies, etc.
Steps towards the rational pharmacotherapy (3)
Patient’s problems are not only confined to complaints due to disease. It may also be related to the need of prophylaxis, sickness certificate, refill of prescription, side effect, etc.
Failure to correctly identify the patient’s problem and establish the diagnosis may lead to irrational use of drugs
Steps towards the rational pharmacotherapy (4)
Objective(s) of treatment:Different problem leads to different objectives/
approach. E.g.:o Excessive smoking → stop the habit o Chronic obstructive pulmonary disease (COPD) →
oxygen, ipratropiumbromideo Asthma → bronchodilator, steroid o Heart failure → diuretics, captopril, spironolactoneo Tuberculosis → antituberculosis agents
Steps towards the rational pharmacotherapy (5)
Suitable choice of drug treatment for individual patients:4 factors to be considered (de Vries et al, 1994):1. Efficacy2. Safety3. Suitability4. Cost
This should be applied at the stage when doctor want to determine the group of drug and the specific drug in the group
Steps towards the rational pharmacotherapy (6)
DRUG EFFICACY SAFETY SUITABILITY COST
chloramphenicol +++ ++ + ++++thiamphenicol ++ +++ + ++amoxicillin ++ ++++ ++++ ++++ciprofloxacin +++ +++ - ++++ceftriaxone +++ +++ - ++
Question: a 32-yr old woman is suffering from typhoid fever. She is not hospitalized and being on her 16th week of pregnancy. What is the most appropriate anti-typhoid drug for her?
Steps towards the rational pharmacotherapy (7)
Education and informationEducation and information for the patient is of paramount important to maintain patient compliance
Check, termination or modification of treatmentDrug treatment cannot be left open endedThe doctor needs to evaluate the outcome of the
treatment, monitor it, modify or terminate it in due time
Conclusions The rational use of medicine is influenced by
many factors The objective, informative, systematic, and
comprehensible drug information is important to support the rational use of medicine
The over-enthusiasm to use new drugs may also contribute to the irrational use of medicine
The PROSPECT approach could become a practical way to implement the rational use of medicine
Thank YouThank You